Patients with the hepatic form of Wilson Disease often present with symptoms related to liver damage. These can include jaundice (yellowing of the skin and eyes), fatigue, abdominal pain, and swelling due to fluid accumulation. In some cases, patients may experience acute liver failure, which is a life-threatening condition. Other symptoms might include easy bruising or bleeding, and in severe cases, neurological symptoms if the disease progresses.

Diagnosing Wilson Disease involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests are crucial to measure copper levels, liver function, and ceruloplasmin, a protein that binds copper. Urine tests can also assess copper excretion. A liver biopsy may be performed to directly measure copper content in the liver. Genetic testing can confirm mutations in the ATP7B gene, which is responsible for the disease.

The primary goal of treatment is to reduce copper accumulation in the body. This is typically achieved through chelation therapy, using medications like penicillamine or trientine, which bind copper and facilitate its excretion. Zinc supplements may also be used to block copper absorption in the intestines. In severe cases, particularly with liver failure, a liver transplant may be necessary.

With early diagnosis and appropriate treatment, the prognosis for patients with Wilson Disease can be favorable. Lifelong treatment is usually required to manage copper levels and prevent organ damage. If left untreated, the disease can lead to severe liver damage, neurological complications, and can be fatal.

Wilson Disease is caused by mutations in the ATP7B gene, which is responsible for copper transport and excretion. This genetic defect is inherited in an autosomal recessive pattern, meaning a person must inherit two copies of the mutated gene, one from each parent, to develop the disease.

Wilson Disease is a rare condition, affecting approximately 1 in 30,000 individuals worldwide. It is equally prevalent in males and females and can present at any age, though symptoms typically appear between the ages of 5 and 35.

The pathophysiology of Wilson Disease involves impaired copper transport due to defective ATP7B protein function. This leads to copper accumulation in the liver, causing cellular damage and liver dysfunction. Over time, excess copper spills into the bloodstream, affecting other organs, particularly the brain, leading to neurological symptoms.

Currently, there is no known way to prevent Wilson Disease, as it is a genetic disorder. However, early detection through family screening and genetic counseling can help manage the condition effectively and prevent complications.

Wilson Disease is a genetic disorder characterized by excessive copper accumulation, primarily affecting the liver and brain. The hepatic form presents with liver-related symptoms and requires a combination of clinical evaluation and laboratory tests for diagnosis. Treatment focuses on reducing copper levels through medication and, in severe cases, liver transplantation. Early diagnosis and lifelong management are crucial for a favorable outcome.

If you or a family member has been diagnosed with Wilson Disease, it's important to understand that it is a manageable condition with proper treatment. Regular follow-ups with your healthcare provider, adherence to prescribed medications, and lifestyle adjustments can help control symptoms and prevent complications. Genetic counseling may be beneficial for family members to assess their risk and consider early screening.